Factoids: 74% of the 142 biotech IPOs since Jan 2013 now trade below their IPO price; the median of these stocks is -35% from its IPO price and is -70% (!) from its all-time high.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.